TRANSCRIPTIONAL MUTAGENESIS BY IONIZING RADIATION
电离辐射转录诱变
基本信息
- 批准号:6513303
- 负责人:
- 金额:$ 29.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-06 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:DNA damage DNA directed RNA polymerase DNA repair DNA replication Escherichia coli RNA biosynthesis alkylating agents gene expression gene mutation genetic transcription guanine analog ionizing radiation mutant nucleic acid sequence oncoprotein p21 radiation genetics site directed mutagenesis tissue /cell culture tumor suppressor genes uracil
项目摘要
The biological endpoints of DNA damage are initiated primarily by its
effects on the DNA and RNA synthesis machinery. RNA polymerase arrest
at or near a DNA damage site is thought to be a key event in
transcription-coupled repair. We have recently shown that in vitro,
certain types of ionizing radiation-induced DNA damages can be
efficiently bypassed by RNA polymerases and produce mutagenic insertions
or deletions in the resulting transcript (transcription mutagenesis).
We believe that such events have potentially profound implications for
both DNA repair pathways as well as the cellular mechanisms that lead
to the production of mutant proteins. Whether or not the failure of a
given DNA damage to block transcription elongation has important
biological consequences is presently unknown. One of the major goals
of this proposal is to test the hypothesis that transcription
mutagenesis can occur in living cells. For these studies we will
utilize both in vitro and in vivo transcription systems. We will
determine the effects of the ionizing radiation-induced base damage
products uracil, dihydrouracil, and 8-oxoguanine and the alkylating
agent-induced base damage product 06methylguanine. An important
criterion for selecting these DNA base damage products is that they also
cause mutagenic nucleotide insertions when encountered by DNA
polymerases. Specifically we will: (1) place these defined base damage
products into DNA templates and determine the effects of such lesions
on the prokaryotic transcription elongation machinery in vitro; (2)
determine the ability of these base damage products to generate mutant
transcripts and proteins in vivo in stationary cultures of E. coli with
different DNA repair backgrounds; (3) place these base damage products
into DNA templates and determine the effects of such damages on the
mammalian transcription elongation machinery in vitro; and (4) determine
the ability of these base damage products to generate mutant transcripts
and proteins in vivo in non- replicating mammalian cells. The in vitro
studies will provide a direct indication of whether or not RNA
polymerase bypass of specific types of ionizing radiation-induced DNA
damages occurs and, if bypass occurs, whether or not such an event
results in mutagenic base insertions in the resulting transcript. The
in vivo studies will address whether or not such mutagenic insertions
occurring at the level of transcription can alter protein expression in
a non-dividing cell.
DNA损伤的生物学终点主要由其启动
对DNA和RNA合成机制的影响。 RNA聚合酶停滞
在DNA损伤部位或附近,被认为是关键事件
转录耦合维修。 我们最近表明,体外,
某些类型的电离辐射诱导的DNA损伤可能是
有效地绕过RNA聚合酶并产生诱变插入
或结果转录本中的缺失(转录诱变)。
我们认为,此类事件对
DNA修复途径以及引导的细胞机制
致突变蛋白的生产。 是否失败
给定DNA对块转录伸长的损害具有重要的
生物学后果目前未知。 主要目标之一
该提议是为了检验转录的假设
活细胞可能发生诱变。 对于这些研究,我们将
利用体外和体内转录系统。 我们将
确定电离辐射诱导的碱基损伤的影响
产品尿嘧啶,二氢酸和8-氧气以及烷基化
代理诱导的基本损伤产物06methylGuanine。 一个重要的
选择这些DNA碱损伤产品的标准是
DNA遇到诱变的核苷酸插入
聚合酶。具体而言,我们将:(1)放置这些定义的基本伤害
产品进入DNA模板并确定此类病变的影响
在体外的原核转录伸长机械上; (2)
确定这些基本损伤产物产生突变体的能力
大肠杆菌固定培养物中的成绩单和蛋白质与
不同的DNA修复背景; (3)放置这些基本损坏产品
进入DNA模板,并确定此类损害对
体外哺乳动物转录伸长机械; (4)确定
这些基本损伤产物产生突变转录本的能力
在非复制哺乳动物细胞中体内的蛋白质。 体外
研究将直接表明RNA是否
特定类型的电离辐射诱导的DNA的聚合酶旁路
发生损害赔偿,如果发生旁路,是否发生此类事件
导致诱变基础插入结果中的转录本。 这
体内研究将解决这种诱变插入是否
在转录水平上发生可以改变
一个非分明的单元。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In vivo technique for determining transcriptional mutagenesis.
用于确定转录突变的体内技术。
- DOI:10.1006/meth.2000.1052
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:You,HJ;Viswanathan,A;Doetsch,PW
- 通讯作者:Doetsch,PW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul William Doetsch其他文献
Paul William Doetsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul William Doetsch', 18)}}的其他基金
Project 2: Oxidative DNA Damage and Genetic Instability In Models Of Intestinal
项目2:肠道模型中的氧化DNA损伤和遗传不稳定性
- 批准号:
8099687 - 财政年份:2010
- 资助金额:
$ 29.08万 - 项目类别:
Project 2: Oxidative DNA Damage and Genetic Instability In Models Of Intestinal
项目2:肠道模型中的氧化DNA损伤和遗传不稳定性
- 批准号:
7511051 - 财政年份:2008
- 资助金额:
$ 29.08万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
8107849 - 财政年份:2007
- 资助金额:
$ 29.08万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7194447 - 财政年份:2007
- 资助金额:
$ 29.08万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7492119 - 财政年份:2007
- 资助金额:
$ 29.08万 - 项目类别:
Radiation-induced DNA Damage and Transcriptional Mutagenesis in Tumor Development
肿瘤发展中辐射诱导的 DNA 损伤和转录突变
- 批准号:
7667814 - 财政年份:2007
- 资助金额:
$ 29.08万 - 项目类别:
相似海外基金
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
$ 29.08万 - 项目类别:
Consequences of retrotransposition on genome integrity
逆转录转座对基因组完整性的影响
- 批准号:
10736406 - 财政年份:2023
- 资助金额:
$ 29.08万 - 项目类别:
Mechanistic Characterization of the Replication Stress Response
复制压力响应的机制表征
- 批准号:
10715216 - 财政年份:2023
- 资助金额:
$ 29.08万 - 项目类别:
Characterization of LINE-1 reverse transcriptase activity
LINE-1 逆转录酶活性的表征
- 批准号:
10604881 - 财政年份:2023
- 资助金额:
$ 29.08万 - 项目类别: